Skip to main content
logo
Pharmaids Pharmaceuticals Limited (BOM:524572)
India flag India · Delayed Price · Currency is INR
30.49
-0.10 (-0.33%)
At close: Jul 27, 2026

Pharmaids Pharmaceuticals Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
278.82278.82195.14153-39.39
Revenue Growth
42.89%42.89%27.54%---53.93%
Gross Profit
107.3107.362.7627.89-9.043.68
Operating Income
-155.65-155.65-151.09-138.32-99.081.28
Net Income
-117.17-117.17-107.77-79.68-75.561.45
Earnings Per Share
-3.31-3.31-3.06-3.51-5.860.14
EPS Growth
-----55.56%

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
1.341.3421.4548.04160.594.07
Total Debt
233.82233.82389.7585.33--
Net Cash (Debt)
-232.49-232.49-368.3-37.29160.594.07
Net Cash Growth
----3841.48%103.44%
Net Cash Per Share
-6.57-6.57-10.44-1.6412.450.40

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-40.57-40.57-139.91-106.2-40.19-2.59
Capital Expenditures
-44.72-44.72-124.81-228.63-16.73-
Free Cash Flow
-85.29-85.29-264.72-334.82-56.92-2.59
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
38.48%38.48%32.16%18.23%-9.34%
Operating Margin
-55.82%-55.82%-77.43%-90.41%-3.25%
Pretax Margin
-58.47%-58.47%-88.55%-102.10%-3.56%
Profit Margin
-42.02%-42.02%-55.23%-52.08%-3.69%
FCF Margin
-30.59%-30.59%-135.66%-218.84%--6.58%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJul '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
-----88.87
PS Ratio
3.803.5012.4111.99-3.28